Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 48

1.

Rethinking rehabilitation after percutaneous coronary intervention: a protocol of a multicentre cohort study on continuity of care, health literacy, adherence and costs at all care levels (the CONCARDPCI).

Norekvål TM, Allore HG, Bendz B, Bjorvatn C, Borregaard B, Brørs G, Deaton C, Fålun N, Hadjistavropoulos H, Hansen TB, Igland S, Larsen AI, Palm P, Pettersen TR, Rasmussen TB, Schjøtt J, Søgaard R, Valaker I, Zwisler AD, Rotevatn S; CONCARD Investigators.

BMJ Open. 2020 Feb 12;10(2):e031995. doi: 10.1136/bmjopen-2019-031995.

2.

Continuity of care and its associations with self-reported health, clinical characteristics and follow-up services after percutaneous coronary intervention.

Valaker I, Fridlund B, Wentzel-Larsen T, Nordrehaug JE, Rotevatn S, Råholm MB, Norekvål TM.

BMC Health Serv Res. 2020 Jan 31;20(1):71. doi: 10.1186/s12913-020-4908-1.

3.

Impella use in acute myocardial infarction complicated by cardiogenic shock and cardiac arrest: Analysis of 10 years registry data.

Davidsen C, Packer EJS, Løland KH, Rotevatn S, Nygreen EL, Eriksen E, Øksnes A, Herstad J, Haaverstad R, Bleie Ø, Tuseth V.

Resuscitation. 2019 Jul;140:178-184. doi: 10.1016/j.resuscitation.2019.04.022. Epub 2019 Apr 19.

PMID:
31009694
4.

Adaptation and psychometric properties of the Norwegian version of the heart continuity of care questionnaire (HCCQ).

Valaker I, Fridlund B, Wentzel-Larsen T, Hadjistavropoulos H, Nordrehaug JE, Rotevatn S, Råholm MB, Norekvål TM; CONCARD Investigators.

BMC Med Res Methodol. 2019 Mar 18;19(1):62. doi: 10.1186/s12874-019-0706-z.

5.

Challenges adhering to a medication regimen following first-time percutaneous coronary intervention: A patient perspective.

Pettersen TR, Fridlund B, Bendz B, Nordrehaug JE, Rotevatn S, Schjøtt J, Norekvål TM; CONCARD Investigators.

Int J Nurs Stud. 2018 Dec;88:16-24. doi: 10.1016/j.ijnurstu.2018.07.013. Epub 2018 Jul 26.

PMID:
30165236
6.

Clinical Effectiveness and Cost Effectiveness of Intracoronary Brachytherapy and Drug Eluting Stents [Internet].

Mørland B, Kløw NE, Rotevatn S, Steigen T, Vatne K, Wisløff T, Kristiansen IS, Norderhaug I.

Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2004.

7.

Continuity of care after percutaneous coronary intervention: The patient's perspective across secondary and primary care settings.

Valaker I, Norekvål TM, Råholm MB, Nordrehaug JE, Rotevatn S, Fridlund B; CONCARD Investigators.

Eur J Cardiovasc Nurs. 2017 Jun;16(5):444-452. doi: 10.1177/1474515117690298. Epub 2017 Jan 1.

8.

Clinical Significance of Late Enhancement and Regional Wall Remodeling Assessed by 3T Magnetic Resonance Imaging.

Larsen TH, Stugaard M, Rotevatn S, Nygård O, Nordrehaug JE.

Clin Med Insights Cardiol. 2015 Apr 15;9:17-24. doi: 10.4137/CMC.S20291. eCollection 2015.

9.

[National guidelines for the interpretation of troponin values in the diagnosis of acute myocardial infarction].

Aakre KM, Rotevatn S, Hagve TA, Bendz B, Landaas S, Trovik T.

Tidsskr Nor Laegeforen. 2013 Nov 12;133(21):E1-6. doi: 10.4045/tidsskr.13.0647. Norwegian. No abstract available.

10.

[New recommendations for the interpretation of troponin values].

Aakre KM, Rotevatn S, Hagve TA, Bendz B, Landaas S, Trovik T.

Tidsskr Nor Laegeforen. 2013 Nov 12;133(21):2241-2. doi: 10.4045/tidsskr.13.0927. Norwegian. No abstract available.

11.

Long-term results after simple versus complex stenting of coronary artery bifurcation lesions: Nordic Bifurcation Study 5-year follow-up results.

Maeng M, Holm NR, Erglis A, Kumsars I, Niemelä M, Kervinen K, Jensen JS, Galløe A, Steigen TK, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Christiansen EH, Lassen JF, Thuesen L; Nordic-Baltic Percutaneous Coronary Intervention Study Group.

J Am Coll Cardiol. 2013 Jul 2;62(1):30-4. doi: 10.1016/j.jacc.2013.04.015. Epub 2013 May 1.

12.

Effects of local delivery of tetradecylthioacetic acid within the injured coronary vessel wall.

Pettersen RJ, Salem M, Rotevatn S, Kuiper KK, Larsen TH, Bohov P, Berge RK, Nordrehaug JE.

Scand Cardiovasc J. 2012 Dec;46(6):366-73. doi: 10.3109/14017431.2012.725477. Epub 2012 Sep 25.

PMID:
22934973
13.

[a woman with recurrence of venous and arterial thrombosis].

Jusufovic M, Thomassen L, Storstein A, Rotevatn S, Lehmann S, Waje-Andreassen U.

Tidsskr Nor Laegeforen. 2011 Jul 1;131(13-14):1303-6. doi: 10.4045/tidsskr.10.0603. Norwegian.

14.

Percutaneous left ventricular assist device can prevent acute cerebral ischaemia during ventricular fibrillation.

Tuseth V, Pettersen RJ, Epstein A, Grong K, Husby P, Farstad M, Wentzel-Larsen T, Rotevatn S, Nordrehaug JE.

Resuscitation. 2009 Oct;80(10):1197-203. doi: 10.1016/j.resuscitation.2009.05.012. Epub 2009 Jul 23.

PMID:
19631443
15.

Percutaneous left ventricular assist in ischemic cardiac arrest.

Tuseth V, Salem M, Pettersen R, Grong K, Rotevatn S, Wentzel-Larsen T, Nordrehaug JE.

Crit Care Med. 2009 Apr;37(4):1365-72. doi: 10.1097/CCM.0b013e31819c0642.

PMID:
19242324
16.

Safety in simple versus complex stenting of coronary artery bifurcation lesions. The nordic bifurcation study 14-month follow-up results.

Jensen JS, Galløe A, Lassen JF, Erglis A, Kumsars I, Steigen TK, Wiseth R, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemelä M, Kervinen K, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Thuesen L; Nordic-Baltic PCI Study Group.

EuroIntervention. 2008 Aug;4(2):229-33.

PMID:
19110788
17.

Implementing a best-treatment strategy with intracoronary brachytherapy for in-stent restenosis in patients at high risk for recurrence.

Kuiper KK, Salem M, Rotevatn S, Mills J, Nordrehaug JE.

Cardiovasc Revasc Med. 2007 Jan-Mar;8(1):9-14.

PMID:
17293263
18.

Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study.

Steigen TK, Maeng M, Wiseth R, Erglis A, Kumsars I, Narbute I, Gunnes P, Mannsverk J, Meyerdierks O, Rotevatn S, Niemelä M, Kervinen K, Jensen JS, Galløe A, Nikus K, Vikman S, Ravkilde J, James S, Aarøe J, Ylitalo A, Helqvist S, Sjögren I, Thayssen P, Virtanen K, Puhakka M, Airaksinen J, Lassen JF, Thuesen L; Nordic PCI Study Group.

Circulation. 2006 Oct 31;114(18):1955-61. Epub 2006 Oct 23.

PMID:
17060387
19.

Long-term results following percutaneous myocardial laser therapy.

Salem M, Rotevatn S, Nordrehaug JE.

Coron Artery Dis. 2006 May;17(4):385-90.

PMID:
16707963
20.

Release of cardiac biochemical markers after percutaneous myocardial laser or sham procedures.

Salem M, Rotevatn S, Stavnes S, Brekke M, Pettersen R, Kuiper K, Ulvik R, Nordrehaug JE.

Int J Cardiol. 2005 Sep 30;104(2):144-51.

PMID:
16168806
21.

Only transient increase of vascular growth factors and microvascular density after percutaneous myocardial laser.

Salem M, Rotevatn S, Pettersen RJ, Kuiper K, Saetersdal T, Nordrehaug JE.

Coron Artery Dis. 2004 Nov;15(7):441-8.

PMID:
15492594
22.

Voluntary running induces fiber type-specific angiogenesis in mouse skeletal muscle.

Waters RE, Rotevatn S, Li P, Annex BH, Yan Z.

Am J Physiol Cell Physiol. 2004 Nov;287(5):C1342-8. Epub 2004 Jul 14.

23.

Usefulness and safety of percutaneous myocardial laser revascularization for refractory angina pectoris.

Salem M, Rotevatn S, Stavnes S, Brekke M, Vollset SE, Nordrehaug JE.

Am J Cardiol. 2004 May 1;93(9):1086-91.

PMID:
15110197
24.

Ribosome distribution in normal and infarcted rat hearts.

Larsen TH, Hesketh JE, Rotevatn S, Greve G, Saetersdal T.

Histochem J. 1994 Jan;26(1):79-89.

PMID:
8169153
25.

Cholesterol induced lipid accumulation in myocardial cells of rats.

Hexeberg S, Willumsen N, Rotevatn S, Hexeberg E, Berge RK.

Cardiovasc Res. 1993 Mar;27(3):442-6.

PMID:
8098271
26.

Fibronectin and laminin in transverse tubules of cardiac myocytes studied by laser confocal microscopy and immunocytochemistry.

Saetersdal T, Larsen T, Rotevatn S, Dalen H, Scheie P.

Histochemistry. 1992 Sep;98(2):73-80.

PMID:
1429022
27.

Intracellular free magnesium concentration: relevance to cardiovascular medicine.

Rotevatn S, Sårheim H, Murphy E.

Acta Physiol Scand Suppl. 1991;599:125-33. Review.

PMID:
1714229
28.

Tissue protection by verapamil in the calcium paradox.

Rotevatn S, Greve G, Oksendal AN, Jynge P.

Scand J Clin Lab Invest. 1990 Oct;50(6):595-604.

PMID:
2174189
29.

Early morphologic changes in cat heart muscle cells after acute coronary artery occlusion.

Greve G, Rotevatn S, Svendby K, Grong K.

Am J Pathol. 1990 Feb;136(2):273-83.

30.

Mitochondrial calcium in hearts subjected to lipid peroxidation with contracture development.

Ytrehus K, Rotevatn S, Løvaas E, Saetersdal T, Mjøs OD.

Basic Res Cardiol. 1989 Nov-Dec;84(6):646-52.

PMID:
2619701
31.

Lifestyle and mortality among Norwegian men.

Rotevatn S, Akslen LA, Bjelke E.

Prev Med. 1989 Jul;18(4):433-43.

PMID:
2798367
32.

Cytosolic free magnesium concentration in cultured chick heart cells.

Rotevatn S, Murphy E, Levy LA, Raju B, Lieberman M, London RE.

Am J Physiol. 1989 Jul;257(1 Pt 1):C141-6.

PMID:
2750886
33.

Effects of verapamil on intracellular lipid accumulation in cat hearts with 3 h of regional-ischaemia.

Jodalen H, Rotevatn S, Stangeland L, Grong K, Vik-Mo H.

Scand J Clin Lab Invest. 1989 Feb;49(1):55-61.

PMID:
2727618
34.

Morphological changes across the border zone of cat hearts subjected to regional ischaemia.

Greve G, Rotevatn S, Stangeland L.

Virchows Arch A Pathol Anat Histopathol. 1989;415(4):323-33.

PMID:
2505444
35.

Effects of verapamil and timolol on cellular morphometric changes in cat hearts with regional ischaemia.

Greve G, Rotevatn S, Berstad K, Jodalen H, Grong K, Stangeland L.

Virchows Arch A Pathol Anat Histopathol. 1988;412(4):291-9.

PMID:
3125669
36.

Cellular morphometric changes in cat hearts subjected to three hours of regional ischaemia.

Greve G, Rotevatn S, Grong K, Stangeland L.

Virchows Arch A Pathol Anat Histopathol. 1988;412(3):205-13.

PMID:
3124342
37.

[Differences in mortality among Norwegian men. The role of smoking, alcohol consumption, physical activity and selected dietary habits].

Akslen LA, Rotevatn S, Bjelke E.

Tidsskr Nor Laegeforen. 1986 Oct 10;106(28):2301-4. Norwegian. No abstract available.

PMID:
3787585
38.

Myocardial cAMP and calcium levels in the calcium paradox.

Rotevatn S, Jodalen H, Røli J, Ogreid D, Oksendal AN, Jynge P.

Basic Res Cardiol. 1986 Jul-Aug;81(4):430-5.

PMID:
3022706
39.

The calcium paradox phenomenon: a flow rate and volume response study of calcium-free perfusion.

Oksendal AN, Jynge P, Sellevold OF, Rotevatn S, Saetersdal T.

J Mol Cell Cardiol. 1985 Oct;17(10):959-72.

PMID:
4068040
40.

Ultrastructural studies of intercalated disc separations in the rat heart during the calcium paradox.

Greve G, Rotevatn S, Saetersdal T, Oksendal AN, Jynge P.

Res Exp Med (Berl). 1985;185(3):195-206.

PMID:
4023429
41.

Propranolol induced lipid accumulation and mitochondrial granularity in myocardial cells.

Rotevatn S, Jodalen HG, Lie RK.

Cardiovasc Res. 1983 May;17(5):290-3.

PMID:
6883405
42.

Effect of isoproterenol on lipid accumulation in myocardial cells.

Jodalen H, Lie R, Rotevatn S.

Res Exp Med (Berl). 1982;181(3):239-44.

PMID:
7163651
43.

Protective effects of verapamil against isoprenaline- induced mobilization of mitochondrial calcium and cellular lipid droplets in the myocardium.

Saetersdal T, Røli J, Engedal H, Jodalen H, Rotevatn S.

Res Exp Med (Berl). 1982;181(1):39-47.

PMID:
7134636
44.

Accumulation of myocardial lipid droplets in dexamethasone-treated mice.

Lie RK, Jodalen HG, Rotevatn S.

Cell Tissue Res. 1981;216(3):661-3.

PMID:
7237524
45.

Calcium and magnesium levels in isolated cardiac mitochondria from mice injected with isoproterenol.

Saetersdal T, Engedal H, Røli J, Jodalen H, Rotevatn S.

Cell Tissue Res. 1981;215(1):13-9.

PMID:
6164487
46.

Development of specific granules in embryonic cardiac myocytes of the human auricular wall.

Saetersdal T, Rotevatn S, Myklebust R, Odegården S.

Anat Embryol (Berl). 1980;160(1):1-9.

PMID:
7469031
47.

Atrial specific granules of the human auricle in embryogenesis, tissue culture, and hypertrophy.

Saetersdal T, Odegården S, Rotevatn S, Engedal H.

Cell Tissue Res. 1980;209(3):345-51.

PMID:
6447541
48.

Effects of isoproterenol on the dense core and perigranular membrane of atrial specific granules.

Saetersdal T, Jodalen H, Lie R, Rotevatn S, Engedal H, Myklebust R.

Cell Tissue Res. 1979 Jun 27;199(2):213-24. Review.

PMID:
383301

Supplemental Content

Loading ...
Support Center